Stocktoria
Lite Strategy, Inc. LITS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2003-12-18
Lite Strategy, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | 22.3% | -75.3% | -185.5% | -173.7% | -92.6% | -940.9% | -1762.4% | 10.3% | — |
| Net margin | — | 27.2% | -65.6% | -133.8% | -118.7% | -170.0% | -342.2% | -2470.3% | 11.5% | — |
| FCF margin | — | -77.3% | -107.6% | -121.0% | -93.9% | 120.2% | -603.1% | — | 14.8% | — |
| Return on assets | -87.2% | 43.0% | -26.5% | -30.6% | -23.7% | -22.5% | -20.3% | -38.3% | 4.8% | -44.2% |
| Return on equity | -94.2% | 53.8% | -130.0% | -103.9% | -83.5% | -61.2% | -35.1% | -79.4% | 5.3% | -50.1% |
| Current ratio | 13.50 | 4.88 | 5.29 | 6.84 | 8.15 | 8.95 | 5.75 | 13.23 | 11.37 | 8.48 |
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.